Reviva Pharmaceuticals, Inc., (Reviva) headquartered in Santa Clara, California, is a fast growing privately held, late-stage clinical
development pharmaceutical company. Reviva is developing a portfolio of internally discovered next generation innovative therapies using chemical genomic driven
approaches and proprietary technologies that addresses unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic and inflammatory
diseases. Reviva has a strong patent portfolio and promising multiple products in the pipeline at various stages of development.
Speed without sacrificing quality is one of the hallmarks of Reviva's product development model. Reviva leadership and management team comprised of highly successful
and experienced professionals in the pharmaceutical industry and have a demonstrated track record of taking drugs through the development process to the global market. Some of our team members contributed to the development of blockbuster category drugs currently in the global market.